$842.7 Million SDS Poly Acrylamide Gel Electrophoresis Market Forecast, 2030 - Featuring Profiles of 13 Companies Including Abcam, Bio-Rad Laboratories, GE Healthcare, and Thermo Fisher Sc...
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for SDS Poly Acrylamide Gel Electrophoresis is estimated at US$591.7 Million in 2023 and is projected to reach US$842.7 Million by 2030, growing at a CAGR of 5.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Key Insights: Market Growth: Understand the significant growth trajectory of the Gels segment, which is expected to reach US$482.2 Million by 2030 with a CAGR of a 5.6%. The Reagents segment is also set to grow at 4.9% CAGR over the next 7 years. Regional Analysis: Gain insights into the U.S. market, estimated at $176.6 Million in 2023, and China, forecasted to grow at an impressive 4.9% CAGR to reach $147.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Why You Should Buy Th
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Recombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028) Boosted by Lower Genetic Sequencing Costs, Powered by AI - Technavio Report [Yahoo! Finance]Yahoo! Finance
- Food Safety Testing Market to Reach $44.1 Billion, Globally, by 2033 at 7% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
- Global Gastric Cancer Diagnostics Market is Expected to Expand at a CAGR of ~7% by 2030 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $340.00 price target on the stock.MarketBeat
BIO
Earnings
- 8/1/24 - Beat
BIO
Sec Filings
- 9/17/24 - Form 3
- 9/12/24 - Form 144
- 9/10/24 - Form 4
- BIO's page on the SEC website